Form
| Dosage
| Status
| Therapeutic Equivalence
| Active Ingred
| Ref.
| Sponsor
| Document
|
CAPSULE, DELAYED RELEASE; ORAL
| 17,500USP/ UNITS;4,200USP/ UNITS;10,000USP/ UNITS
| Prescription
|
| PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
| Pancrelipase
| JANSSEN PHARMS
| 22523
2011-06-29 Letter 2011-02-17 Summary Review 2011-01-03 Review 2010-04-30 Other 2010-04-14 Letter 2010-04-12 Label 2010-04-12 Medication Guide |
CAPSULE, DELAYED RELEASE; ORAL
| 43,750USP/ UNITS;10,500USP/ UNITS;25,000USP/ UNITS
| Prescription
|
| PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
| Pancrelipase
| JANSSEN PHARMS
| " |
CAPSULE, DELAYED RELEASE; ORAL
| 61,000USP/ UNITS;21,000USP/ UNITS;37,000USP/ UNITS
| Prescription
| (Reference Drug)
| PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
| Pancrelipase
| JANSSEN PHARMS
| " |
CAPSULE, DELAYED RELEASE; ORAL
| 70,000USP/ UNITS;16,800USP/ UNITS;40,000USP/ UNITS
| Prescription
|
| PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
| Pancrelipase
| JANSSEN PHARMS
| " |